Poxel Secures Patent in China for Imeglimin Use in Type-2 Diabetic Patients with Renal Impairment
Poxel Advances Global Strategy with Key Patent for Imeglimin in China Expanding Innovative Treatments for Chronic Metabolic Diseases Poxel, a clinical-stage biopharmaceutical company focused on developing cutting-edge treatments for chronic…
Aseptic Filling Machine Market Forecast to 2035 Key Players Profiled
Aseptic Filling Machine Market: Industry Trends and Global Forecasts to 2035 The global market for aseptic filling machines has witnessed remarkable growth over recent years, driven by advancements in pharmaceutical…
Gaza Ceasefire Brings Hope, but Health System Challenges Remain
WHO Welcomes Gaza Ceasefire but Highlights Immense Health Challenges Ahead The World Health Organization (WHO) has welcomed the Gaza ceasefire and the associated hostage and prisoner release deal, bringing a…
Leaps by Bayer Launches Global Survey on Breakthrough Tech Attitudes
Global Survey Explores Public Sentiment on Breakthrough Technologies As Global Survey leaders convene for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm…
Experimental Breast Cancer Drug Shows Potential to Treat Certain Blood Cancers
Two groundbreaking studies conducted by researchers at Washington University School of Medicine in St. Louis have identified a promising approach to halting the progression of several forms of blood cancer…
Ceasefire in Gaza Offers Hope Amidst Significant Challenges to Rebuild the Health System
The World Health Organization (WHO) has welcomed the recently brokered ceasefire in Gaza, along with the hostage and prisoner release agreement. This development offers a glimmer of hope for millions…
Medical Device Breakthrough WuXi AppTec to Strategically Sell U.S. Testing Operations to NAMSA
Impact on WuXi AppTec’s Operations WuXi AppTec, a global leader in providing comprehensive R&D and manufacturing services for the pharmaceutical and life sciences industries, recently announced the signing of a…
Groundbreaking Biomedical Collaboration Neuraly & Enigma Biomedical USA Partner on PET Imaging Biomarker PMI04
Biomedical Neuraly & Enigma Biomedical USA Partner on PET Imaging Biomarker PMI04 Neuraly, a biotechnology company specializing in the development of innovative treatments for neurodegenerative diseases, has entered into a…
FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding Use in Inflammatory Bowel Disease
Eli Lilly and Company has announced that the U.S. FDA has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn’s disease in adults. This approval marks a…
WuXi Biologics CEO Dr. Chris Chen: Ready for Rapid Expansion
WuXi Biologics, delivered a keynote address at the 43rd J.P. Morgan Healthcare Conference, providing an insightful look into the company’s latest achievements, strategies, and future outlook. His presentation highlighted WuXi…
UCB Highlights a Decade of Growth and Patient-Centered Innovation Strategy
UCB is A global biopharmaceutical leader committed to improving the lives of people living with severe diseases, highlighted its decade of growth and strategic priorities at the 43rd J.P. Morgan…
Walgreens Resources for the ‘Quad-demic’ Vaccines, Treatments, and Support
Walgreens Steps Up Amid the ‘Quad-Demic’: Vaccines, Testing, Treatments, and Support The term “tripledemic” gained traction not too long ago to describe the simultaneous surges of flu, COVID-19, and respiratory…